We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > TQ Formula

News List

Novatek Seeks EUA for TQ Formula to Treat COVID ContractPharma
November 02, 2021
Novatek Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company, announced topline results from a Phase 2 randomized, controlled multicenter trial...
Novatek seeks EUA after its Oral TQ Formula Significantly improved Total Symptom Burden in a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of COVID-19 Patients in the Outpatient Setting prnewswire
November 02, 2021
Novatek Pharmaceuticals, Inc. ("Novatek") a privately held, clinical-stage biopharmaceutical company today announced topline results from a Phase 2 randomized, controlled multicenter trial (BOSS-Covid-19 study)...